- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04243980
Anatomical Femoral Stem in Total Hip Arthroplasty (THR)
January 26, 2020 updated by: Raja Hakim, HaEmek Medical Center, Israel
Short Term Results of Short Anatomical Femoral Stem in Total Hip Arthroplasty - Prospective Study
A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Raja Hakim, M.D.
- Phone Number: 00972546612251
- Email: raja.hakim@icloud.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients aged 18 - 90 who had THR as an elective surgery
Description
Inclusion Criteria:
- age 18-90
- patients who had THR as an elective surgery
- patients who had THR with short femoral anatomical stem
Exclusion Criteria:
- severe osteoporosis with Dorr C classification
- s/p bilateral hip arthroplasty
- non-complaint patients
- revision surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Patients after total hip arthroplasty with short femoral stem
|
Patients with osteoarthritis after total hip arthroplasty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Femoral anteversion
Time Frame: Post-Operatively, through study completion, an average of 2 years
|
comparing femoral anteversion after THR using CT scan
|
Post-Operatively, through study completion, an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Harris Hip Score
Time Frame: 6 weeks, 3 month, 6 month post-operative
|
The HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points). Where a score < 70 indicating a poor result and those of 90-100 indicating an excellent result |
6 weeks, 3 month, 6 month post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2020
Primary Completion (Anticipated)
January 1, 2021
Study Completion (Anticipated)
January 1, 2022
Study Registration Dates
First Submitted
January 23, 2020
First Submitted That Met QC Criteria
January 26, 2020
First Posted (Actual)
January 28, 2020
Study Record Updates
Last Update Posted (Actual)
January 28, 2020
Last Update Submitted That Met QC Criteria
January 26, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- EMC-19-0100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Satisfaction
-
Shaukat Khanum Memorial Cancer Hospital & Research...Enrolling by invitationSatisfaction, Patient | SatisfactionPakistan
-
Acibadem UniversityCompletedPatient Satisfaction | Patient Relations, NurseTurkey
-
Cedars-Sinai Medical CenterTerminated
-
Universitair Ziekenhuis BrusselUnknownPatient Satisfaction | Patient PreferenceBelgium
-
Samsun UniversityRecruiting
-
Fatma mahannaCompleted
-
Medical University of ViennaCompletedPatient SatisfactionAustria
-
University of UtahActive, not recruitingPatient SatisfactionUnited States
-
Ziekenhuis Oost-LimburgCompleted
-
Konya Meram State HospitalCompletedPatient SatisfactionTurkey
Clinical Trials on Short anatomical femoral stem in THR
-
Ewha Womans UniversityCompletedOsteoarthritis of HipKorea, Republic of
-
Association pour le Développement et l'Enseignement...RecruitingOsteoarthritis, HipFrance
-
Ain Shams UniversityCompletedLength of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic LesionArthroplasty | Metastatic Bone Tumor | Pathological FractureEgypt
-
Hip Innovation TechnologyRecruitingOsteoarthritis, Hip | Avascular Necrosis of Hip | Degenerative Joint Disease | Traumatic Arthropathy-HipUnited States
-
Fred Hutchinson Cancer CenterTerminatedGlioblastoma | GliosarcomaUnited States